Search

Your search keyword '"Marshall, John L"' showing total 920 results

Search Constraints

Start Over You searched for: Author "Marshall, John L" Remove constraint Author: "Marshall, John L"
920 results on '"Marshall, John L"'

Search Results

2. Patterns of Failure Following Preoperative Chemotherapy and Stereotactic Body Radiation Therapy and Resection for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer

5. PBRM1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair system

6. Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study

11. Multiomic Characterization Reveals a Distinct Molecular Landscape in Young-Onset Pancreatic Cancer

12. Phase I/II Trial of Labetuzumab Govitecan (Anti-CEACAM5/SN-38 Antibody-Drug Conjugate) in Patients With Refractory or Relapsing Metastatic Colorectal Cancer

13. Large-scale analysis of KMT2 mutations defines a distinctive molecular subset with treatment implication in gastric cancer

14. Metastatic Colorectal Cancer

15. Molecular characteristics of BRCA1/2 and PALB2 mutations in pancreatic ductal adenocarcinoma

16. Molecular profile of BRCA-mutated biliary tract cancers

17. Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patients

19. CEA

23. Phase I Study of Hypofractionated Proton Beam Radiotherapy in Adjuvant Pancreatic Cancer (PROTON-PANC)

33. Supplementary Table S2 from Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers

34. Data from Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers

35. Figure S2 from Molecular Characterization of Appendiceal Goblet Cell Carcinoid

36. Supplementary appendix from Molecular Characterization of Appendiceal Goblet Cell Carcinoid

37. Supplemental Figure 1 from Association of Homologous Recombination–DNA Damage Response Gene Mutations with Immune Biomarkers in Gastroesophageal Cancers

38. Table S2 from Molecular Characterization of Appendiceal Goblet Cell Carcinoid

39. Supplementary Figure Legend from Association of Homologous Recombination–DNA Damage Response Gene Mutations with Immune Biomarkers in Gastroesophageal Cancers

40. Data from Association of Homologous Recombination–DNA Damage Response Gene Mutations with Immune Biomarkers in Gastroesophageal Cancers

41. Supplementary Data from Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets

42. Supplementary Figure from Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets

43. Supplementary Table from Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets

44. Data from Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets

45. Figure S5 from The Landscape of Alterations in DNA Damage Response Pathways in Colorectal Cancer

46. Supplementary Methods from The Landscape of Alterations in DNA Damage Response Pathways in Colorectal Cancer

47. Supplementary Table S3 from Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer

49. Figure S2 from Clinical Validation of a Machine-learning–derived Signature Predictive of Outcomes from First-line Oxaliplatin-based Chemotherapy in Advanced Colorectal Cancer

50. Supplementary Table S2 from Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal Cancer

Catalog

Books, media, physical & digital resources